Dualitybio Inc.
Clinical trials sponsored by Dualitybio Inc., explained in plain language.
-
New hope for Hard-to-Treat cancers: DB-1310 enters human trials
Disease control Recruiting nowThis study tests a new drug called DB-1310 in people with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. About 1,000 adults will take part in two phases: first to check safety, then to measure…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for advanced cancers? early trial launches
Disease control Recruiting nowThis early-stage study tests a new drug called DB-1311/BNT324 in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors. About 862 adults with various ad…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New hope for advanced cancer: DB-1419 enters human trials
Disease control Recruiting nowThis study tests a new drug called DB-1419 in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 360 people will take part in this early-phase …
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC
-
New lupus shot enters human testing – could it tame the disease?
Disease control Recruiting nowThis study tests an experimental injection called DB-2304 in healthy volunteers and people with lupus (SLE or CLE). The main goal is to check safety and side effects, not to cure the disease. About 148 participants will be monitored closely. If safe, the drug may help control lup…
Phase: PHASE1, PHASE2 • Sponsor: DualityBio Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC